Viral Vector Manufacturing Facility and Cell Therapies have signed an MoU to explore strategic collaboration opportunities aimed at strengthening the onshore development and manufacture of Advanced Therapy Medicinal Products.
New Australian collaboration to build gene and cell therapy production
July 15, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech -
Lumos Diagnostics signs FebriDx US Distribution Agreement with PHASE Scientific
July 16, 2025 - - Australian Biotech -
Noxopharm confirms first patient dosed in SOF-SKN HERACLES trial
July 16, 2025 - - Australian Biotech -
Final days to help build Australia’s longest running life sciences benchmark survey
July 15, 2025 - - Latest News -
New Australian collaboration to build gene and cell therapy production
July 15, 2025 - - Latest News -
The need to correct a profound misconception of what ethical decision-making is and is not
July 15, 2025 - - Latest News